ITH the recent recognition of coronary artery disease (CAD) as a major disease, 201T1 myocardial scintigraphy with stress testing has been established as one of the most important methods for detecting this disease. Although the number of patients with CAD increases with age, diagnosis of CAD in elderly patients is often difficult because they can not adequately perform exercise tests as a result of their noncardiac disorders. Intravenous dipyridamole stress 201T myocardial scintigraphy (D-T1) is an equally or even more sensitive method than exercise scintigraphy for detecting coronary artery disease1)-7) and it requires no physical exertion from the patients. Therefore, it is a more suitable test than the exercise stress test for elderly patients with suspected CAD. However, it is widely known that elderly patients have less tolerance to drugs and can easily suffer from their adverse effects. Although intravenous dipyridamole is reported to be relatively safe,8)-10) its safety in elderly patients has not been established, with the exception of a few reports.11),12) Therefore, our study seeks to determine whether or not D-T1 can be performed safely in the elderly, in comparison to young patients. Furthermore, we examined whether this test was equally effective in detecting CAD among those patients who underwent coronary angiography, though the number was relatively small. Additionally we studied the relationship between symptoms or ECG changes noted during the dipyridamole stress test and the scintigraphic results. Fig. 1 . Division of area in left ventricular Bull's eye presentation . We divided the left ventricle into 5 subareas, apical (1), septal (2), inferior (3), lateral (4), and anterior (5), and geometrically classified the dipyridamole induced perfusion defect area into these subareas. When a significantly obstructed coronary artery coincided with some of these subareas with reversible perfusion defects, we judged that the cardiac imaging accurately detected the ischemic area. pain and ST-T changes and 28% of those without adverse effects (Table VII) .
METHODS
There was a significant difference between the incidence of dipyridamole induced PD in the patients with chest pain or ST-T changes and patients suffering from no adverse effect. The patients with both chest pain and ST-T change tended to show more dipyridamole induced PD in comparison to patients experiencing no adverse effect.
DISCUSSION
One of the major findings in this study was that the intravenous dipyridamole stress test is almost as safe in elderly patients as in younger patients. The sensitivity of D-T1 using SPECT for detection of IHD is reported to be 89%.14) Since 75% of our patients in each group presented a dipyridamoleinduced or persistent perfusion defect on scintigram, it may be reasonable to conclude that more than half of the patients in each group had IHD. Therefore, our results suggest that D-T1 can be performed safely even in elderly patients with IHD. Lam et al. also studied the safety of intravenous dipyridamole in patients over 70 years old and reported that the incidence of adverse effects was nearly equal in elderly (63.4%) and in younger patients (60.6%) with the exception of nausea, which occurred more frequently in elderly patients.12) Gerson et al. also reported that the incidence of adverse effects was 33% in the patients over 65 years and 36% in younger patients.11) Although both of these previous studies noted that reflex tachycardia was more pronounced in younger patients, our results showed that hemodynamic changes were similar in both groups.
In the present study, aminophylline was more frequently used in the elderly patients, though this difference was not statistically significant (P=14). The major reason for aminophylline administration was chest pain and ECG changes. However, because chest pain or discomfort is a subjective symptom, we can not objectively judge whether the adverse effects were more severe in the elderly patients or not. On the other hand, aminophylline tended to be more frequently used in the elderly patients, in comparison to younger patients, although ischemic ECG changes and hemodynamic changes occurred to a similar extent. This fact leads us to conclude that aminophylline was used much earlier in the elderly patients than in the younger patients because adverse effects in the elderly patients seemed more serious to the attending physician. Since in our series, CAG was performed selectively in 8 of 21 elderly patients with PD and 20 of 24 younger patients with PD, we can not precisely compare the ability of D-T1 to detect CAD in the two groups. Under this limitation, the positive predictive values of D-T1 were not significantly different statistically in the two groups (62.5% for the elderly patients and 85% for the younger patients) and the accuracy for detecting ischemic areas was satisfactory in both groups (100% in elderly patients and 92.3% in younger patients).
In the present study, the number of patients who underwent coronary angiography after positive dipyridamole-induced PD was significantly different between the two groups (8 of 21 patients in the elderly group vs. 20 of 24 patients in the younger group). This may be partially because the younger patients were more closely examined preoperatively and when the scintigraphic result was positive, a more precise examination by CAG was necessary. In addition, another possible reason is that the daily activity of the elderly patients was so low that coronary revascularization was not necessary.
In this study, two adverse effects were weakly but significantly correlated to scintigraphic ischemia. The positive predictive values were 52% for chest pain, 57% for ST-T changes and 56% for both chest pain and ST-T changes, while 28% of the patients without adverse effects presented scintigraphic ischemia. However, we do not consider the presence of an adverse effect to be clinically useful for predicting myocardial ischemia, since even if the patient presents with chest pain and/or ST-T change, we can only say that half of such patients have scintigraphic ischemia. On the other hand if the patient has no adverse effect, one fourth of such patients have scintigraphic ischemia. However, like other reports,15)16) we conclude that there may be some relationship between these adverse effects and myocardial ischemia.
In summary, these results indicate that D-T1 can be performed safely even in elderly patients as long as aminophylline can be readily used. Additionally , the ability to predict the existence of CAD and to detect the ischemic area is not different in the two subsets.
